TD Ameritrade Investment Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-3,906
| Closed | -$316K | – | 329 |
|
|
2023
Q2 | $316K | Sell |
3,906
-168
| -4% | -$13.6K | ﹤0.01% | 133 |
|
|
2023
Q1 | $324K | Sell |
4,074
-286
| -7% | -$22.7K | ﹤0.01% | 141 |
|
|
2022
Q4 | $295K | Sell |
4,360
-1,504
| -26% | -$102K | ﹤0.01% | 171 |
|
|
2022
Q3 | $292K | Sell |
5,864
-1,884
| -24% | -$93.8K | ﹤0.01% | 181 |
|
|
2022
Q2 | $432K | Sell |
7,748
-1,438
| -16% | -$80.2K | ﹤0.01% | 164 |
|
|
2022
Q1 | $510K | Sell |
9,186
-560
| -6% | -$31.1K | ﹤0.01% | 183 |
|
|
2021
Q4 | $546K | Buy |
9,746
+1,952
| +25% | +$109K | ﹤0.01% | 172 |
|
|
2021
Q3 | $271K | Sell |
7,794
-702
| -8% | -$24.4K | ﹤0.01% | 195 |
|
|
2021
Q2 | $356K | Buy |
8,496
+504
| +6% | +$21.1K | ﹤0.01% | 188 |
|
|
2021
Q1 | $279K | Hold |
7,992
| – | – | ﹤0.01% | 197 |
|
|
2020
Q4 | $279K | Buy |
7,992
+198
| +3% | +$6.91K | ﹤0.01% | 197 |
|
|
2020
Q3 | $271K | Buy |
7,794
+714
| +10% | +$24.8K | ﹤0.01% | 195 |
|
|
2020
Q2 | $232K | Buy |
7,080
+492
| +7% | +$16.1K | ﹤0.01% | 202 |
|
|
2020
Q1 | $198K | Buy |
6,588
+72
| +1% | +$2.16K | ﹤0.01% | 199 |
|
|
2019
Q4 | $189K | Buy |
6,516
+2,612
| +67% | +$75.8K | ﹤0.01% | 198 |
|
|
2019
Q3 | $101K | Buy |
3,904
+2,904
| +290% | +$75.1K | ﹤0.01% | 214 |
|
|
2019
Q2 | $26K | Buy |
1,000
+896
| +862% | +$23.3K | ﹤0.01% | 313 |
|
|
2019
Q1 | $3K | Buy |
104
+20
| +24% | +$577 | ﹤0.01% | 495 |
|
|
2018
Q4 | $2K | Buy |
84
+38
| +83% | +$905 | ﹤0.01% | 539 |
|
|
2018
Q3 | $1K | Buy |
+46
| New | +$1K | ﹤0.01% | 545 |
|